Variation in post-stroke QOL estimates misleading

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.316, 2001-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy for prevention of post-stroke depression

By Ramasubbu Rajamannar

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2177-2187

Informa Healthcare

Access to resources Recommend Favorite

Minocycline may improve post-stroke outcomes

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Botulinum toxin A alleviates post-stroke spasticity

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The Therapeutic Potential of Amphetamines in Post-stroke Recovery

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 49-55

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Stroke Immunodepression and Infection: An Emerging Concept

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 2, 2010-04 ,pp. : 91-97

Bentham Science Publishers

Access to resources Recommend Favorite